Creating Equity in COVID-19 Testing: 3Cor Bio Wins $30,000 Perlman Grand Prize in Virtual Startup Challenge Share Article Ranjan Pati (C'21, W'21), founder and CEO of 3Cor Bio PHILADELPHIA (PRWEB) May 03, 2021 Venture Lab is pleased to announce the winner of the fifth annual Startup Challenge, sponsored by Eric Aroesty, C’92: 3Cor Bio, founded by Ranjan Pati (C’21, W’21). 3Cor Bio produces low cost, accessible diagnostics for infectious diseases, including a COVID-19 diagnostics device. Due to the COVID-19 pandemic, Venture Lab held the competition in a virtual setting on April 23rd and April 30th. The COVID-19 pandemic revealed fundamental flaws in health care’s diagnostics and testing infrastructure. Pati founded 3Cor Bio to democratize diagnostics and to make testing more equitable. With a small saliva sample and a smart phone, 3Cor Bio’s diagnostic platform provides a COVID diagnosis within four minutes with 97% accuracy costing $4.67 per test. While 3Cor Bio expects to receive emergency approval from the FDA in the coming months, Pati also plans to expand the testing platform to diagnose all infectious diseases including influenza, malaria and sexually transmitted diseases.